In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Focus on - 23 June

results may have significant impact on the indications of endocardial LV lead implantation

EHRA-EUROPACE - CARDIOSTIM 2015 congress represents a great opportunity to present our mortality and safety results in long term outcome of endocardial cardiac resynchronization therapy (CRT). Our results may have significant impact on the indications of endocardial LV lead implantation.

Our group developed transapical left ventricular (TALV) lead implantation in 2007, which is a minimally invasive, surgical CRT implantation technique. We aimed to determine the long-term outcome of this procedure. After failed percutaneous coronary sinus approach, 26 CRT candidates were included into the study. During follow-up, we performed cerebral CT scans to detect thromboembolic complications related to TALV lead.

Eleven out of 26 (47%) patients were alive after median follow-up of 40±24,5 months. Major ischaemic stroke occurred in 2 cases, transient ischaemic stroke in 1 case. In 2 out of 10 followed-up patients chronic ischaemic lesion was revealed.

We believe this is the first study reporting long-term outcome after transapical CRT: Patients that underwent this procedure had an identical mortality rate to CRT, although cerebrovascular event rate is high and raises concerns.

Doctor Kis Zsuzsanna, Hungary:
Young Investigator Award Clinical Science nominee, abstract entitled: "Long- term follow- up after left ventricular endocardial resynchronisation therapy: mortality and thromboembolic complications"

a new approach to tracking and reporting cardiac device-related adverse events

Digital technologies are changing the way we do things – and are also changing the way we can conduct our biomedical researches. Healthcare data is rapidly translated into electronic formats. However, adverse events reporting has not taken full advantage of these electronic data sources.

In order to address this issue, our proposed solution is the "Cardiac Implantable Electronic Devices Adverse Events Reporting System" (CIED_AERS) which uses a new approach to tracking and reporting cardiac device-related adverse events. This platform is a web-based remote tool designed at our institution (University of São Paulo, Brazil) and has been used in 12 cardiology centers. Following implementation, more than 2,500 patients have been included over a period of 15 months.

At this point, I would like to highlight that this is the first time I will be attending "EHRA EUROPACE-CARDIOSTIM" and it is an honour to present our research results.

Doctor Silva Katia, Brazil:
Presenter of the abstract entitled "Cardiac implantable electronic devices adverse events reporting system (CIED_AERS): rationale and preliminary results " that will be on display for the duration of the congress in the Poster Area.

I'm delighted to be nominated for the EHRA Inventors Award

I am very much looking forward to discussing our research with colleagues from all over the world!

I'm delighted to be nominated for the Inventors Awards at the EHRA EUROPACE - CARDIOSTIM 2015 for the development of a through-needle intracardiac echo for transseptal puncture. We are really excited to be presenting this work for the first time at this prestigious conference, which has resulted from several years of development and collaboration between Barts Heart Centre (Prof. Richard Schilling) and Medical Physics, UCL (Dr Adrien Desjardins).

Personally, I'm looking forward to seeing the latest developments that will help us better manage our arrhythmia patients in a practical sense, particularly those related to AF ablation. Finally, the prospect of a few days of Italian sun in such a magnificent city is particularly appealing for any UK-based cardiologist (in the breaks between sessions, of course)!

Dr Malcolm Finlay, UK, Consultant Cardiologist & Hon. Lecturer (QMUL)
Presenter in the Inventors Awards session: "Through-needle intracardiac echocardiography for transseptal puncture using a novel optical pulse-echo ultrasound technique."


Online post-congress resources

Please note that  all the EHRA EUROPACE-CARDIOSTIM 2015 online scientific resources  will be available online with a restricted access to 2015 EHRA Members.



Find your face in the crowd on our Facebook gallery